Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Internal Radiation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03324958
What this trial is testing

VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.

Who this might be right for
Endometrial Cancer
Centre Hospitalier Universitaire de Saint Etienne 24
Not applicableLooking for participantsNCT05665738
What this trial is testing

Two-fraction HDR Monotherapy for Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaLocalized Prostate Carcinoma
University of California, San Francisco 17
Not applicableStudy completedNCT03243825
What this trial is testing

Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer

Who this might be right for
Cervical Cancer
Chinese Academy of Medical Sciences 120
Not applicableActive Not RecruitingNCT01583920
What this trial is testing

Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Not applicableLooking for participantsNCT07318415
What this trial is testing

Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT04100174
What this trial is testing

Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy

Who this might be right for
Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 150
Not applicableStudy completedNCT01757717
What this trial is testing

Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis

Who this might be right for
Metastatic or Recurrent Lesions in the SpineMetastatic or Recurrent Lesions in the Pelvis
Memorial Sloan Kettering Cancer Center 3
Not applicableActive Not RecruitingNCT02400658
What this trial is testing

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Shayna Showalter, MD 358
Testing effectiveness (Phase 2)WithdrawnNCT01659424
What this trial is testing

Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy and FOLFOX Chemotherapy for Rectal Cancer

Who this might be right for
Rectal Cancer
Beth Israel Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06642220
What this trial is testing

Ablative Radioembolization of Renal Cell Carcinoma Trial

Who this might be right for
Renal Cell Carcinoma (RCC)Radioembolization
Derek W. Cool 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07368985
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Who this might be right for
Cervical Cancer by FIGO Stage 2018Squamous Cell Carcinoma FIGO 2018 Stage IIIA, IIIB, IIIC1-IIIC2Adenocarcinoma or Adeno-squamous Carcinoma Stage IB3-IIIC2
Prof. Dr. Remi A. Nout 87
Not applicableLooking for participantsNCT07155850
What this trial is testing

Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Locally AdvancedUnresectable
BetaGlue Therapeutics SpA 10
Early research (Phase 1)Study completedNCT00003876
What this trial is testing

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Not applicableStudy completedNCT06916546
What this trial is testing

SIRT or TACE Plus Lenvatinib and PD-(L)1 Inhibitor in High Burden HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 238
Not applicableWithdrawnNCT03437915
What this trial is testing

BrUOG 351: PRE-OPERATIVE APBI USING NIBB

Who this might be right for
Breast CancerInvasive Breast CancerDuctal Carcinoma in Situ
Jaroslaw Hepel
Large-scale testing (Phase 3)Looking for participantsNCT07293468
What this trial is testing

Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tuen Mun Hospital 106
Not applicableUnknownNCT01524718
What this trial is testing

Internal Fixation of Hip Fractures Using Intraoperative Simultaneous Two Axis View

Who this might be right for
Fracture Neck of Femur
Meir Medical Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04758533
What this trial is testing

Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy

Who this might be right for
Diffuse Intrinsic Pontine GliomaMedulloblastoma, Childhood, Recurrent
Hospital Infantil Universitario Niño Jesús, Madrid, Spain 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04690348
What this trial is testing

Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

Who this might be right for
Recurrent Brain Metastases
Memorial Sloan Kettering Cancer Center 103
Large-scale testing (Phase 3)Active Not RecruitingNCT06900543
What this trial is testing

Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere

Who this might be right for
Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD. 108
Next Page